<VariationArchive RecordType="classified" VariationID="13563" VariationName="NG_008332.2:g.48605_58661del" VariationType="Deletion" Accession="VCV000013563" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-08" DateCreated="2022-07-08" MostRecentSubmission="2022-07-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28602" VariationID="13563">
      <GeneList>
        <Gene Symbol="ITGB3" FullName="integrin subunit beta 3" GeneID="3690" HGNC_ID="HGNC:6156" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47253827" stop="47313743" display_start="47253827" display_stop="47313743" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45331207" stop="45390076" display_start="45331207" display_stop="45390076" Strand="+" />
          </Location>
          <OMIM>173470</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NG_008332.2:g.48605_58661del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.32</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>11.2-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_481" sequenceAccession="LRG_481">
            <Expression>LRG_481:g.48605_58661del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008332.2" sequenceAccession="NG_008332" sequenceVersion="2" change="g.48605_58661del">
            <Expression>NG_008332.2:g.48605_58661del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="173470.0011" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 173470.0011 from the sequence across the breakpoint in Figure 4 of the paper by Rosenberg et al., 1997 (PubMed 9160670).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_008332.2:g.48605_58661del AND Glanzmann thrombasthenia 2" Accession="RCV000014531" Version="29">
        <ClassifiedConditionList TraitSetID="66021">
          <ClassifiedCondition DB="MedGen" ID="C5543273">Glanzmann thrombasthenia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-05-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-05-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-07-08" MostRecentSubmission="2022-07-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9160670</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="66021" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56009" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 23</ElementValue>
                <XRef Type="MIM" ID="619267" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia 2</ElementValue>
                <XRef ID="MONDO:0031009" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GT2</ElementValue>
                <XRef Type="MIM" ID="619267" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT23</ElementValue>
                <XRef Type="MIM" ID="619267" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543273" DB="MedGen" />
              <XRef ID="MONDO:0031009" DB="MONDO" />
              <XRef Type="MIM" ID="619267" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="34782" SubmissionDate="2010-12-30" DateLastUpdated="2022-07-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="173470.0011_GLANZMANN THROMBASTHENIA 2" title="ITGB3, 11.2-KB DEL_GLANZMANN THROMBASTHENIA 2" />
        <ClinVarAccession Accession="SCV000034782" DateUpdated="2022-07-08" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-05-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated Iraqi-Jewish families with Glanzmann thrombasthenia (GT2; 619267), Rosenberg et al. (1997) identified an 11.2-kb deletion between an Alu sequence in intron 9 and exon 13 in the GP3A gene. They showed that in the general Iraqi-Jewish population living in Israel, the frequency of heterozygotes for an 11-bp deletion (173470.0014) is 1 in 114 and that for the 11.2-kb deletion is less than 1 in 700. Haplotype analyses indicated that each mutation originated in a distinct founder.</Attribute>
              <Citation>
                <ID Source="PubMed">9160670</ID>
              </Citation>
              <XRef DB="OMIM" ID="619267" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <Name>ITGB3, 11.2-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11.2-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="173470.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLANZMANN THROMBASTHENIA 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="34782" TraitType="Disease" MappingType="Name" MappingValue="GLANZMANN THROMBASTHENIA 2" MappingRef="Preferred">
        <MedGen CUI="C5543273" Name="Glanzmann thrombasthenia 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

